2007
DOI: 10.1016/j.ajem.2006.10.017
|View full text |Cite
|
Sign up to set email alerts
|

Atrial fibrillation in the Wolff-Parkinson-White syndrome: ECG recognition and treatment in the ED

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
45
0
2

Year Published

2010
2010
2023
2023

Publication Types

Select...
3
2
2

Relationship

0
7

Authors

Journals

citations
Cited by 56 publications
(52 citation statements)
references
References 24 publications
0
45
0
2
Order By: Relevance
“…The failure to prevent an increased ventricular response leads the study to call for the establishment of the safety of amiodarone in WPW-AF [5]. The findings support the notion that amiodarone may not be the safe pharmacological treatment of choice for rate control in WPW-AF [2,4,5,13,16].…”
Section: Discussionmentioning
confidence: 70%
See 3 more Smart Citations
“…The failure to prevent an increased ventricular response leads the study to call for the establishment of the safety of amiodarone in WPW-AF [5]. The findings support the notion that amiodarone may not be the safe pharmacological treatment of choice for rate control in WPW-AF [2,4,5,13,16].…”
Section: Discussionmentioning
confidence: 70%
“…Furthermore, the review notes that out of ten patients with WPW-AF who had ventricular tachydysrhythmias after antidysrhythmic drug administration, seven of the cases involved IV amiodarone [16]. Fengler et al, in a case report, caution against the use of amiodarone as well, stating that IV amiodarone usage in WPW-AF is documented to cause ventricular rate acceleration leading to ventricular fibrillation [4]. Additionally, Schützenberger et al [13] caution against the use of amiodarone in WPW-AF presenting a case report of an increased ventricular response secondary to accelerated conduction via the accessory pathway.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Acutely, people with WPW who are experiencing tachyarrhythmias may require synchronized electrical cardioversion if their condition is critical (e.g., they are hypotensive or lethargic with altered mental status); if they are stable, medical treatment may be used [11]. Patients with AF and rapid ventricular response are often treated with amiodarone or procainamide to stabilize their heart rate.…”
Section: Discussionmentioning
confidence: 99%